Remicade and Blood thyroid stimulating hormone increased - a phase IV clinical study of FDA data

Summary:

Blood thyroid stimulating hormone increased is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Calcium, and have Headache.

The phase IV clinical study analyzes which people have Blood thyroid stimulating hormone increased when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Blood thyroid stimulating hormone increased?

Blood thyroid stimulating hormone increased is found to be associated with 677 drugs and 843 conditions by eHealthMe. Check the latest studies of Blood thyroid stimulating hormone increased.

On Aug, 03, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 15 people (0.01%) have Blood thyroid stimulating hormone increased.

Could Remicade cause Blood thyroid stimulating hormone increased?

Among these 15 people:

How long have people been on Remicade when they have Blood thyroid stimulating hormone increased? *

What is the gender of people who have Blood thyroid stimulating hormone increased when taking Remicade? *

female: 60 %
male: 40 %

What is the age of people who have Blood thyroid stimulating hormone increased when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Blood thyroid stimulating hormone increased? *

Joint Pain: 5 people, 33.33%
Weight Increased: 4 people, 26.67%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 3 people, 20.00%
Dizziness: 3 people, 20.00%
Fever: 3 people, 20.00%
White Blood Cell Count Increased: 2 people, 13.33%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 13.33%
Muscle Aches (muscle pain): 2 people, 13.33%
Nausea (feeling of having an urge to vomit): 2 people, 13.33%
International Normalised Ratio Increased: 2 people, 13.33%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Headache (pain in head): 2 people, 13.33%
Thyroid Diseases: 1 person, 6.67%
Sleep Disorder: 1 person, 6.67%
Pain: 1 person, 6.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Blood thyroid stimulating hormone increased?

- Check whether Blood thyroid stimulating hormone increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Blood thyroid stimulating hormone increased treatments and more:

Blood thyroid stimulating hormone increased (11,145 reports)

How severe was Blood thyroid stimulating hormone increased and when was it recovered:

Blood thyroid stimulating hormone increased in Remicade

Expand to all the drugs that have ingredients of infliximab:

Blood thyroid stimulating hormone increased and drugs with ingredients of infliximab (20 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood thyroid stimulating hormone increased:

Blood thyroid stimulating hormone increased (677 drugs)

Browse all the conditions that are associated with Blood thyroid stimulating hormone increased:

Blood thyroid stimulating hormone increased (843 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.